AM
American Well Corporation
AMWL · NYSE
$13.50 +0.52% (+$0.07)
1M +12.28%
Market Cap $229.6M
P/E Ratio -
Div. Yield -
ROE 33.27%
Bulios Fair Price
$11.77
12.8% downside
Current Price
$13.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AMWL is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 1.05x
P/B 1.04x
P/E N/A
Growth
2 /100
Declining Rev. growth 3.47%
Book val. growth 39.50%
EPS growth N/A
Profitability
19 /100
Weak Gross margin 48.42%
Net margin 35.75%
Op. margin 35.23%
Quality
8 /100
Poor ROIC 32.34%
ROE 33.27%
ROA 23.87%
Debt
69 /100
Low Debt/Equity 0.01x
Current ratio 2.90x
Int. coverage -124.39x
Stability
35 /100
Moderate Beta 1.71x
Rev. volatility 2.69%
EPS volatility 118.72%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AMWL
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Ido Schoenberg
Employees
562
Headquarters
Boston
Upcoming events
03 NOV
Earnings
Upcoming earnings report